Product Information
CLOTRIMAZOLE-BETAMETHASONE CRM is a generic product labeled by Actavis Pharma, Inc., priced at $0.1781 per GM under NDC 00472037945. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Aug 2, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5; 10 mg/g; mg/g
Manufacturer
Actavis Pharma, Inc.NDC
00472037945
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA076002FDA Approved
8/2/2002
TE Code
AB
On Market Since
12/16/2003
Pharmacological Classes
Price Statistics
The NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 77.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1781 per GM |
|---|---|
| All-time high | $0.8300 (Jan 15, 2014) |
| All-time low | $0.1494 (Oct 18, 2023) |
| 52-week high | $0.1905 |
| 52-week low | $0.1781 |
| Median price | $0.2391 |
| Average price | $0.3253 |
| Largest weekly change | +23.8% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clotrimazole and Betamethasone Dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Azole Antifungal class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOTRIMAZOLE-BETAMETHASONE CRM?
The current National Average Drug Acquisition Cost (NADAC) for CLOTRIMAZOLE-BETAMETHASONE CRM, manufactured by Actavis Pharma, Inc., is $0.1781 per GM (NDC 00472037945), effective Sep 30, 2026.
How has the price of CLOTRIMAZOLE-BETAMETHASONE CRM changed over time?
Over the history we have for it, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has declined 77.6%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLOTRIMAZOLE-BETAMETHASONE CRM?
Since Nov 28, 2013, the NADAC for CLOTRIMAZOLE-BETAMETHASONE CRM has ranged from a low of $0.1494 (Oct 18, 2023) to a high of $0.8300 (Jan 15, 2014), with a median of $0.2391 per GM.
Are there cheaper alternatives to CLOTRIMAZOLE-BETAMETHASONE CRM?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLOTRIMAZOLE-BETAMETHASONE CRM in a comparable dosage form, but none are currently priced below it.
Who manufactures CLOTRIMAZOLE-BETAMETHASONE CRM?
CLOTRIMAZOLE-BETAMETHASONE CRM (NDC 00472037945) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.